GPRC5A and permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome: Knockout of GPRC5a reduced the proliferation and migration ability of PaCa cell lines and suppressed the chemotherapy drug resistance of gemcitabine, oxaliplatin, and fluorouracil in PaCa cells.